Bleeding versus stent thrombosis: can short DAPT be safe in complex lesions?
Chairperson: Alexandre ABIZAID, Philip URBAN
Objectives:
To discuss changes in DAPT guidelines and their application in daily practiceTo identify the patient populations that suffer from bleeding complications and cannot tolerate DAPT duration
To understand how selection of a polymer-free stent can support optimising treatment of patients
Lectures
Session objectives
A. Abizaid
Evidence for optimal DAPT duration following stenting is inconclusive
A. Iniguez Romo
LIVE demonstration from Contilia Heart and Vascular Center - Essen, Germany
Are polymer-free drug-coated stents the solution for short DAPT?
T. Kinnaird
Clinical evidence on the horizon
G. Sardella